Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASTRO 2022 | Importance of global cooperation for clinical trial recruitment

Alejandra Mendez Romero • 28 Oct 2022
ASTRO 2022
Gastrointestinal Cancer Liver Cancer

Alejandra Mendez Romero, MD, PhD, Erasmus MC Cancer Institute, Rotterdam, Netherlands, discusses the importance of global cooperation for clinical trial recruitment, in order to combat the problem of trials ending early due to low accrual. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Alejandra Mendez Romero

4:03
Results of Phase II trial comparing TACE and SBRT for hepatocellular carcinoma
Alejandra Mendez Romero • 28 Oct 2022
3:00
Challenges and unmet needs of treating patients with hepatocellular carcinoma with radiotherapy
Alejandra Mendez Romero • 28 Oct 2022
2:01
Rationale and study design of Phase II trial comparing TACE and SBRT for hepatocellular carcinoma
Alejandra Mendez Romero • 28 Oct 2022

Related Videos

0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
1:33
Peptide vaccines with ICIs for fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
The content of VJOncology is intended for healthcare professionals